Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.

Eli Lilly says it plans to apply for U.S. Food and Drug Administration (FDA) approval by the end of the year to market the ...

The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the ...

In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 ...

In a clinical trial, the company's weight loss pill resulted in a nearly 12% weight loss at 72 weeks for participants who took the highest dose of the medication. On average, participants lost 7.8% to ...

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight ...

Shares in Novo Nordisk rose as much as 14% on Thursday after trial data from Eli Lilly's experimental weight-loss pill fell ...

Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight in a late-stage ...

Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 shots.

The White Sox have signed shortstop Billy Carlson, reports Jim Callis of MLB.com. The Sox selected Carlson with their first-round pick, 10th overall, in last week’s draft.

The White House is introducing another rescissions package "soon" that will include cuts to education funding.

The White Sox made their first-round pick official on Tuesday by signing Billy Carlson for $6,235,900, as first reported by Jim Callis of MLB Pipeline.